Overview
Christopher Lao is an Oncologist in Ann Arbor, Michigan. Dr. Lao is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Metastatic Uveal Melanoma. Dr. Lao is currently accepting new patients.
His clinical research consists of co-authoring 88 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Hematology/Oncology Center
Parvez Khan is an Oncologist in Garden City, Michigan. Dr. Khan has been practicing medicine for over 49 years and is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Agranulocytosis, Chronic Familial Neutropenia, Idiopathic Neutropenia, and Bone Marrow Aspiration. Dr. Khan is currently accepting new patients.
Ascension St John Hospital
Zyad Kafri is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Kafri is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Appendix Cancer, Lynch Syndrome, Colorectal Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Kafri is currently accepting new patients.
Mclaren Flint
Vatsala Katragadda is a Hematologist and an Oncologist in Flint, Michigan. Dr. Katragadda is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphofollicular Hyperplasia. Dr. Katragadda is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Lao isElite. Learn about Melanoma.
- Distinguished
- Melanoma of the EyeDr. Lao isDistinguished. Learn about Melanoma of the Eye.
- Merkel Cell CarcinomaDr. Lao isDistinguished. Learn about Merkel Cell Carcinoma.
- Advanced
- Basal Cell Skin CancerDr. Lao isAdvanced. Learn about Basal Cell Skin Cancer.
- GliomaDr. Lao isAdvanced. Learn about Glioma.
- Metastatic Brain TumorDr. Lao isAdvanced. Learn about Metastatic Brain Tumor.
- Metastatic Uveal MelanomaDr. Lao isAdvanced. Learn about Metastatic Uveal Melanoma.
- Posterior Fossa TumorDr. Lao isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- Anal CancerDr. Lao isExperienced. Learn about Anal Cancer.
- Brain TumorDr. Lao isExperienced. Learn about Brain Tumor.
- Cervical CancerDr. Lao isExperienced. Learn about Cervical Cancer.
- Chromophobe Renal Cell CarcinomaDr. Lao isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Lao isExperienced. Learn about Clear Cell Sarcoma.
- Eccrine PorocarcinomaDr. Lao isExperienced. Learn about Eccrine Porocarcinoma.